Abstract:In the present study, we evaluated the effect of the α 2 -adrenoceptor agonist clonidine on tyrosine hydroxylase activity in adrenal medulla and brain of spontaneously hypertensive rats and Wistar Kyoto rats. Six-week-old animals were treated with clonidine (100 μ g/kg body weight, daily, i.p.) for 4 weeks. Treatment with clonidine significantly reduced mean arterial blood pressure in spontaneously hypertensive rats to values similar to normotensive Wistar Kyoto rats. In the adrenal medulla of spontaneously hypertensive rats, clonidine treatment produced a significant increase in tyrosine hydroxylase activity with higher V max values and no changes in K M values. This effect was accompanied by a significant increase in tyrosine hydroxylase protein expression and of noradrenaline and adrenaline levels. In the brain of spontaneously hypertensive rats, treatment with clonidine produced a significant decrease in tyrosine hydroxylase activity with lower V max values and no changes in K M values accompanied by a significant decrease in tyrosine hydroxylase protein expression and of dopamine and noradrenaline levels. In Wistar Kyoto rats, clonidine treatment had no effect on tyrosine hydroxylase activity and protein expression or catecholamine levels in adrenal medulla or brain. Clonidine treatment significantly reduced noradrenaline and adrenaline plasma levels in spontaneously hypertensive rats and Wistar Kyoto rats. In conclusion, treatment with the α 2 -adrenoceptor agonist clonidine prevented the increase in mean arterial blood pressure in young spontaneously hypertensive rats. This effect was accompanied by opposite effects on tyrosine hydroxylase activity in spontaneously hypertensive rat adrenal medulla and brain: an increase in adrenal medulla and a decrease in brain, bringing sympathetic function to a similar profile found in normotensive Wistar Kyoto rats.The endogenous catecholamines noradrenaline and adrenaline mediate sympathetic regulation of blood pressure [1]. These effectors of the sympathetic nervous system are synthesized within sympathetic neurons and chromaffin cells of the adrenal medulla by a well-defined series of reactions that start with the conversion of tyrosine to 3,4-dihydroxyphenylalanine mediated by tyrosine hydroxylase, the initial and rate-limiting enzyme of the pathway [2]. Noradrenaline is the principal neurotransmitter of sympathetic neurons, whereas adrenaline is secreted from the chromaffin cells of the adrenal medulla into the circulation. Whereas the actions of noradrenaline are mostly restricted to the sites of release from sympathetic nerves, adrenaline acts as a neurohormone to activate cardiovascular and metabolic responses via the blood stream.Increased sympathetic nervous system activity with higher tyrosine hydroxylase activity and catecholamine levels are common features of hypertension in human beings and in the spontaneously hypertensive rat [3,4], an animal model used to investigate the mechanisms of essential hypertension [5]. It is noteworthy that in spont...